Databricks is Raising $10B Series J Investment at $62B Valuation
Funding led by new investor Thrive Capital Company expects to cross $3B in revenue run rate and achieve positive free cash flow in fourth quarter
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)
STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn\'s disease (CD) and ulcerative coliti
DELTA ELECTRONICS POWERS SINGAPORE'S NATIONAL CORAL RESTORATION EFFORTS WITH ADVANCED AUTOMATION AND MONITORING TECHNOLOGY
SINGAPORE,Dec. 10,2024-- Delta,a global leader in power management and IoT-based smart green solutions,has joined the National Parks Board of Singapore\'s (NParks) 100k Corals Initiative to support co
District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism
SHENZHEN,China,Dec. 10,2024-- Luohu district of Shenzhen,an economic powerhouse in South China,signed a total investment of 62.1 billion yuan (US$8.5 billion) at the 2024 Shenzhen Global Investment Pr
Quanta Services Australia chooses IFS Cloud to drive consolidation and fuel growth
Industry-leading ERP solution will enable infrastructure solutions provider to standardize operations,reduce tech complexity and support dynamic expansion.
PwC Wins Two Accolades at the International Innovation Awards 2024
KUALA LUMPUR,Malaysia,Dec. 10,2024-- PricewaterhouseCoopers International Limited (PwC) has earned prestigious recognition at the International Innovation Awards 2024,organized by Enterprise Asia,secu
J.F. Lehman & Company Raises $2.2 Billion for Oversubscribed Fund VI
NEW YORK,Dec. 11,2024-- J.F. Lehman & Company ("JFLCO"),a leading middle-market private equity firm focused exclusively on the aerospace,defense,maritime,government and environmental se
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months
ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med
State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carries out intelligent upgrading of the power grid
ARTUSH,China,Dec. 11,2024-- Recently,the transformer maintenance personnel of the State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carried out the installation of current
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion
HONG KONG,Dec. 11,2024-- Recently,Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston,USA. As a global leader in drug research,devel